3M™ Red Dot™ 2670-3Recalls & reported problems
3m Company · 3M™ Red Dot™ ECG Monitoring Electrodes, 2670-3, Radiolucent, Soft Cloth · Class 2
All models of 3M Red Dot (8)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 10707387789234), received between May 11, 2023 and Mar 28, 2024 — classified as 2 injuries.
The most frequently reported specific device problem is “Human-Device Interface Problem” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Human-Device Interface Problem1
Patient problems
- Caustic/Chemical Burns1
- Skin Tears1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryMar 28, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A CUSTOMER PRESENTED TO THE HOSPITAL FOR DIZZINESS DUE TO POTENTIAL HEART ISSUES AND 3M¿ RED DOT¿ ECG MONITORING ELECTRODES, 2670-3 WERE ALLEGEDLY APPLIED FOR HEART MONITORING. TWO DAYS POST ELECTRODE APPLICATION, THE PATIENT ALLEGEDLY EXPERIENCED REDNESS, PAIN, BLISTERING, SEVERE BURNS WITH SCARRING. THE CUSTOMER PRESENTED TO URGENT CARE THE SAME DAY, WAS DIAGNOSED WITH A 2CM X 2CM LEFT UPPER CHEST ERYTHEMATOUS CHEMICAL BURN WITH BLISTERING, AND WAS DISCHARGED THE SAME DAY WITH A TREATMENT PLAN NOTED AS APPLICATION OF SILVER SULFADIAZINE 1% EXTERNAL CREAM, TWICE A DAY FOR 10 DAYS, 8 GRAMS.
Patient problems: Caustic/Chemical Burns
MAUDE report 18994902 ↗InjuryMay 11, 2023Human-Device Interface Problem; Human-Device Interface Problem
A HOSPITAL REPORTED "SOME" PATIENTS ALLEGEDLY EXPERIENCED SKIN TEARING WITH THE USE OF THE 3M¿ RED DOT¿ REPOSITIONABLE MONITORING ELECTRODE, 2670-3. THE ELECTRODE LEADS ARE REPORTEDLY DIFFICULT TO REMOVE AFTER A SHORT DURATION OF USE, EVEN WITH THE USE OF AN ADHESIVE REMOVER. NO MEDICAL INTERVENTION WAS REPORTED.
Patient problems: Skin Tears
MAUDE report 16911090 ↗
Other Electrode, electrocardiograph devices
- Vermed A10091-30Graphic Controls Acquisition Corp · Electrode, Electrocardiograph132 reports
- 3M™ 22283m Company · Electrode, electrocardiograph2 recalls0 reports
- 3M™ Red Dot™ 22283m Company · Electrode, electrocardiograph1 recall4 reports
- Vital Signs™ 2464AAO-20AirLife Finland Oy · Electrode, electrocardiograph51 reports
- Vermed IP-Set M5 RT Adult-USGraphic Controls Acquisition Corp · Electrode, Electrocardiograph1 recall0 reports
- Vermed IP-Set 5V RT Adult-USGraphic Controls Acquisition Corp · Electrode, Electrocardiograph1 recall0 reports
- Vermed IP-Set N3-Pediatric-USGraphic Controls Acquisition Corp · Electrode, Electrocardiograph1 recall0 reports
- Vermed IP-Set 6V RT ADULT-USGraphic Controls Acquisition Corp · Electrode, Electrocardiograph1 recall0 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page